Who is sponsoring NCT03309423?

NCT03309423 is sponsored by Aalborg University.

What drugs are being tested in NCT03309423?

Interventions in NCT03309423: venous to arterial conversion (v-TAC).

What condition does NCT03309423 study?

NCT03309423 studies Respiratory Insufficiency, Metabolic Disease, Acidosis, Alkalosis, Sepsis, Abdomen, Acute.

Is NCT03309423 still recruiting?

NCT03309423 is currently status unknown. Last updated 13 October 2017.

Last reviewed 2017-10-13 · How we verify

NCT03309423

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Is Venous to Arterial Conversion (v-TAC) of Blood Gas Reliable in Critical Ill Patients in the ICU?

Status unknown Last updated 13 October 2017

What this trial tests

trial testing venous to arterial conversion (v-TAC) in Respiratory Insufficiency in 50 participants. Status unknown.

Timeline

9 October 2017

Primary endpoint
30 January 2018

30 March 2018

Quick facts

Lead sponsor	Aalborg University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	50
Start date	9 October 2017
Primary completion	30 January 2018
Estimated completion	30 March 2018
Sites	1 location across Denmark

Drugs / interventions tested

venous to arterial conversion (v-TAC)

Conditions studied

Respiratory Insufficiency — all drugs for Respiratory Insufficiency →
Metabolic Disease — all drugs for Metabolic Disease →
Acidosis — all drugs for Acidosis →
Alkalosis — all drugs for Alkalosis →

Sponsor

Aalborg University

Who can join

Eligibility, any sex, with Respiratory Insufficiency or Metabolic Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Objective: Arterial blood gas (ABG) is essential in the clinical assessment of potential acutely ill patients venous to arterial conversion (v-TAC), a mathematical method, has recently been developed to convert peripheral venous blood gas (VBG) values to arterialized VBG (aVBG) values. The aim of this study is to test the reliability of aVBG compared to ABG in an intensive care unit (ICU) setting. Method: Consecutive patients admitted to the ICU with pH values \<7,35 or \>7,45 are included in this study. Paired ABG and aVBG samples are drawn from patients via arterial catheter, central venous catheter and/or peripheral venous catheter and compared.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Respiratory Insufficiency

Currently open trials in the same condition.

NCT06653166 — Retrospective Data Analysis With the Aim to Determine the Success Rate of Endotracheal Intubation in the First Attempt i · active not recruiting
NCT06483984 — Noninvasive Ventilation Facemasks Favoring Carbon Dioxide Washout · NA · recruiting
NCT05906030 — Diaphragm Dysfunction and Ultrasound Perioperatively · recruiting
NCT06442267 — Comparing Anticoagulation Strategies Using UFH, Argatroban and LMWH for ECMO Support · Phase 4 · recruiting
NCT06494215 — Comparison of Different Methods to Calculate Pendelluft by Electrical Impedance Tomography in Mechanically Ventilated Pa · NA · recruiting

Other Aalborg University trials

Trials by the same sponsor.

NCT07580989 — Network Effects of Left M1 rTMS: A TMS-EEG Study · NA · recruiting
NCT07395882 — A New Model to Induce Itch and Inflammation · NA · not yet recruiting
NCT07395869 — Off-set Analgesia Induced by Cold Temperature · NA · not yet recruiting
NCT07266103 — Mechanistic Study of Personalized rTMS in Chronic Pain · NA · not yet recruiting
NCT07373392 — Effects of LP-LDL® on Lipid Metabolism, Glycemic Control, Inflammatory Markers, and Cognitive Function in Individuals Wi · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03309423 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Aalborg University
Last refreshed: 13 October 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03309423.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing